Skip to main content
SpringerLink
Log in

Clinical Features, Diagnostic Evaluation, and Management of COVID-19 Patients

  • Chapter
  • First Online:
Coronavirus Therapeutics – Volume II

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1353))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

2019-nCoV:

2019-novel coronavirus

ACE2:

Angiotensin-converting enzyme 2

ARDS:

Acute respiratory distress syndrome

COVID-19:

Coronavirus disease 2019

E:

Envelope protein

FAO:

Food and Agriculture Organization of the United Nations

FDA:

Food and Drug Administration

IFN:

Interferon

MERS-CoV:

Middle East respiratory syndrome-related coronavirus

MODS:

Multiple organ dysfunction syndromes

OIE:

World Organisation for Animal Health

SARS-CoV:

Severe acute respiratory syndrome-related coronavirus

SARS-CoV-2:

Severe acute respiratory syndrome-related coronavirus 2

WHO:

World Health Organization

References

  • (WHO) (Press release) (2020) WHO director-General’s opening remarks at the media briefing on COVID-19 -11 March 2020. World Health Organization

    Google Scholar 

  • AFP (2020) Updated: WHO now doesn’t recommend avoiding ibuprofen For COVID-19 symptoms. ScienceaAlert

    Google Scholar 

  • Agoro R, Taleb M, Quesniaux VFJ, Mura C (2018) Cell Iron status influences macrophage polarization. PLoS One. https://doi.org/10.1371/journal.pone.0196921

  • Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Tao Q, Sun Z, Xia L (2020) Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology. https://doi.org/10.1148/radiol.2020200642

  • Al-Bari MAA (2017) Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacol Res Perspect. https://doi.org/10.1002/prp2.293

  • Al-Khafaji AH, Sharma S, Eschun G, Pinsky MR (2020) Multiple organ dysfunction syndrome in sepsis clinical presentation

    Google Scholar 

  • American College of Radiology (2020) ACR recommendations for the use of chest radiography and Computed Tomography (CT) for suspected COVID-19 infection. American College of Radiology

    Google Scholar 

  • Amgen (2020) Amgen and adaptive biotechnologies announce strategic partnership to develop a therapeutic to prevent or treat COVID-19. Amgen

    Google Scholar 

  • Anderson RM, Heesterbeek H, Klinkenberg D, Déirdre Hollingsworth T (2020) How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. https://doi.org/10.1016/S0140-6736(20)30567-5

  • AppliedTherapeutics (2020) Applied therapeutics announces IND and investigator-initiated studies of AT-001 in critical COVID-19 patients

    Google Scholar 

  • Arya R, Das A, Prashar V, Kumar M (2020) Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs. ChemRxiv Org. https://doi.org/10.26434/chemrxiv.11860011.v2

  • Aylward, Bruce (WHO); Liang, Wannian (PRC) (2020) Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19), The WHO-China Joint Mission on Coronavirus Disease 2019. WHO

    Google Scholar 

  • Bae S, Kim M-C, Kim JY, Cha H-H, Lim JS, Jung J, Kim M-J et al (2020) Effectiveness of surgical and cotton masks in blocking SARS-CoV-2: a controlled comparison in 4 patients. Ann Intern Med. https://doi.org/10.7326/M20-1342.

  • Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, Pan I et al (2020) Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. https://doi.org/10.1148/radiol.2020200823

  • Balfour H (2020) Nafamostat inhibits SARS-CoV-2 infection, preventing COVID-19 transmission. Drug Target Rev

    Google Scholar 

  • Baranovich T, Wong S-S, Armstrong J, Marjuki H, Webby RJ, Webster RG, Govorkova EA (2013) T-705 (Favipiravir) induces lethal mutagenesis in Influenza A H1N1 viruses in vitro. J Virol. https://doi.org/10.1128/jvi.02346-12

  • Barclay E, Scott D, Animashaun C (2020) The US doesn’t just need to flatten the curve. It needs to “raise the Line”. Vox

    Google Scholar 

  • Biesalski HK (2016) Nutrition meets the microbiome: micronutrients and the microbiota. Ann N Y Acad Sci. https://doi.org/10.1111/nyas.13145

  • Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M (2007) Transmission of Influenza A in human beings. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(07)70029-4

  • Cai Q, Yang M, Liu D, Chen J, Shu D, Xia J, Liao X et al (2020) Experimental treatment with Favipiravir for COVID-19: an open-label control study. Engineering. https://doi.org/10.1016/j.eng.2020.03.007

  • Calder PC (2013) Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. https://doi.org/10.1111/j.1365-2125.2012.04374.x

  • Campbell, Charlie (2020) The Wuhan pneumonia crisis highlights the danger in China’s Opaque way of doing things. Time

    Google Scholar 

  • Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L et al (2020) A trial of Lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. https://doi.org/10.1056/nejmoa2001282

  • Capatides C (2020) Austria is making everyone who goes inside a supermarket wear a face mask. CBS News

    Google Scholar 

  • Carr AC, Maggini S (2017) Vitamin C and immune function. Nutrients. https://doi.org/10.3390/nu9111211

  • CDC (2020a) 2019 novel coronavirus, Wuhan, China: Prevention & Treatment

    Google Scholar 

  • CDC (2020b) Coronavirus disease 2019 (COVID-19): COVID-19 situation summary (CDC)

    Google Scholar 

  • CDC (2020c) Coronavirus disease 2019 (COVID-19): infection control. U.S. Centers for Disease Control and Prevention (CDC)

    Google Scholar 

  • CDC (2020d) Coronavirus disease 2019 (COVID-19): Prevent Getting Sick. U.S. Centers for Disease Control and Prevention (CDC)

    Google Scholar 

  • CDC (2020e) Coronavirus Disease 2019 (COVID-19): public health recommendations for community-related exposure. U.S. Centers for Disease Control and Prevention (CDC)

    Google Scholar 

  • CDC (2020f) People who need extra precautions. U.S. Centers for Disease Control and Prevention (CDC)

    Google Scholar 

  • CDC (2020g) Public health recommendations after travel-associated COVID-19 Exposure. U.S. Centers for Disease Control and Prevention (CDC)

    Google Scholar 

  • CDC COVID-19 Response Team (2020) Severe outcomes among patients with coronavirus disease 2019 (COVID-19) – United States, February 12-March 16, 2020. U.S. Centers for Disease Control and Prevention (CDC). https://doi.org/10.15585/mmwr.mm6912e2

  • CEL-SCICorporation (2020) CEL-SCI initiates development of immunotherapy to treat COVID-19 coronavirus infection. CEL-SCI Corporation

    Google Scholar 

  • Chan JFW, Yuan S, Kok KH, Kelvin Kai Wang To, Chu H, Yang J, Xing F et al (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet. https://doi.org/10.1016/S0140-6736(20)30154-9

  • Chanda W, Joseph TP, Guo XF, Wang WD, Liu M, Vuai MS, Padhiar AA, Zhong MT (2018) Effectiveness of Omega-3 polyunsaturated fatty acids against microbial pathogens. J Zhejiang Univ Sci B. https://doi.org/10.1631/jzus.B1700063

  • Chen H, Zhang Z, Wang L, Huang Z, Gong F, Li X, Chen Y, Jinzi JW (2020a) First clinical study using HCV protease inhibitor Danoprevir to treat naive and experienced COVID-19 patients. MedRxiv. https://doi.org/10.1101/2020.03.22.20034041

  • Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J et al (2020b) Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet. https://doi.org/10.1016/S0140-6736(20)30360-3

  • Cheung JCH, Ho LT, Cheng JV, Cham EYK, Lam KN (2020) Staff safety during emergency airway management for COVID-19 in Hong Kong. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30084-9

  • Chin AWH, Chu JTS, Perera MRA, Hui KPY, Yen H-L, Chan MCW, Peiris M, Poon LLM (2020) Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe. https://doi.org/10.1016/s2666-5247(20)30003-3

  • Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Sneha S, Jain et al (2020) Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation. https://doi.org/10.1161/circulationaha.120.046941

  • ClinicalTrials.gov (2020a) Eculizumab (Soliris) in COVID-19 Infected Patients (SOLID-C19)

    Google Scholar 

  • ClinicalTrials.gov (2020b) Nitric oxide gas inhalation for severe acute respiratory syndrome in COVID-19. (NOSARSCOVID)

    Google Scholar 

  • ClinicalTrials.gov (2020c) ODYSSEY: a study to investigate the efficacy of Tradipitant in treating severe or critical COVID-19 infection

    Google Scholar 

  • Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T et al (2020) Detection of 2019 novel coronavirus (2019-NCoV) by real-time RT-PCR. Euro Surveill Bull Eur Sur Les Maladies Transmissibles/Eur Commun Dis Bull. https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045

  • Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S (2020) A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. https://doi.org/10.1016/j.jcrc.2020.03.005

  • Day M (2020) COVID-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. https://doi.org/10.1136/bmj.m1086

  • de Wilde AH, Zevenhoven-Dobbe JC, van der Meer Y, Thiel V, Narayanan K, Makino S, Snijder EJ, van Hemert MJ (2011) Cyclosporin A inhibits the replication of diverse coronaviruses. J Gen Virol. https://doi.org/10.1099/vir.0.034983-0

  • Dong L, Hu S, Gao J (2020a) Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Therapeutics. https://doi.org/10.5582/ddt.2020.01012

  • Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (2020b) Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. https://doi.org/10.1542/peds.2020-0702

  • Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, Brown TS et al (2020) Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2020.03.031

  • Duan K, Liu B, Li C, Zhang H, Yu T, Jieming Q, Zhou M (2020) Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.2004168117

  • Elfiky AA (2020) Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci. https://doi.org/10.1016/j.lfs.2020.117477

  • EliLilly&Abcellera (2020) AbCellera and Lilly to Co-develop antibody therapies for the treatment of COVID-19. Eli Lilly & Abcellera

    Google Scholar 

  • Gao F, Chiu SM, Motan DAL, Zhang Z, Chen L, Ji HL, Tse HF, Fu QL, Lian Q (2016) Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. https://doi.org/10.1038/cddis.2015.327

  • Gao J, Tian Z, Xu Y (2020) Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. https://doi.org/10.5582/bst.2020.01047

  • Gasmi A, Noor S, Tippairote T, Dadar M, Menzel A, Bjørklund G (2020) Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic. Clin Immunol. https://doi.org/10.1016/j.clim.2020.108409

  • Gombart AF, Pierre A, Maggini S (2020) A review of micronutrients and the immune system–working in harmony to reduce the risk of infection. Nutrients. https://doi.org/10.3390/nu12010236

  • Grace Hauck (2020) ‘A Game Changer’: FDA authorizes abbott labs’ portable, 5-minute coronavirus test the size of a toaster. USA Today

    Google Scholar 

  • Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T et al (2020) Compassionate use of Remdesivir for patients with severe Covid-19. N Engl J Med:1–10. https://doi.org/10.1056/NEJMoa2007016

  • Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, Zou W et al (2005) Multiple organ infection and the pathogenesis of SARS. J Exp Med. https://doi.org/10.1084/jem.20050828

  • Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, Dela Cruz CS (2020) et al, Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. https://doi.org/10.1093/cid/ciaa310

  • Haryanto B, Suksmasari T, Maggini S (2015) Multivitamin supplementation supports immune function and ameliorates conditions triggered by reduced air quality. Vitam Miner. https://doi.org/10.4172/2376-1318.1000128

  • Heikkinen T, Järvinen A (2003) The common cold. Lancet. https://doi.org/10.1016/S0140-6736(03)12162-9

  • Hoffmann M, Kleine-Weber H, Schroeder S, Mü MA, Drosten C, Pö S, Krü N et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor article SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:1–10. https://doi.org/10.1016/j.cell.2020.02.052

    Article  Google Scholar 

  • HopeBiosciences (2020) FDA approval to commence first stem cell clinical trial for protection against COVID-19. Hope Biosciences

    Google Scholar 

  • https://www.worldometers.info/coronavirus/ (2020) COVID-19 coronavirus outbreak. https://www.worldometers.info/coronavirus/

  • Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. https://doi.org/10.1016/S0140-6736(20)30183-5

  • Husson MO, Ley D, Portal C, Gottrand M, Hueso T, Desseyn JL, Gottrand F (2016) Modulation of host Defence against bacterial and viral infections by Omega-3 polyunsaturated fatty acids. J Infect. https://doi.org/10.1016/j.jinf.2016.10.001

  • Hutt D (2020) Coronavirus: Czechs facing up to COVID-19 crisis by making masks mandatory. Euronews

    Google Scholar 

  • I-MAB Biopharma (2020) I-MAB Biopharma Announces Development of TJM2 to treat cytokine release syndrome associated with severe and Critically-Ill Patients With Coronavirus Disease (COVID-19)

    Google Scholar 

  • InnovationPharmaceuticals (2020) Innovation pharmaceuticals Brilacidin Received by U.S. Regional biocontainment laboratory; Testing against coronavirus (COVID-19). Innovation Pharmaceuticals

    Google Scholar 

  • Iwabuchi K, Yoshie K, Kurakami Y, Takahashi K, Kao K, Morishima T (2020) COVID-19. Three cases improved with inhaled Ciclesonide in the early to middle stages of pneumonia. (In Japanese)

    Google Scholar 

  • Jin Z, Xiaoyu D, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B et al (2020) Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature. https://doi.org/10.1038/s41586-020-2223-y

  • Kahn JS, McIntosh K (2005) History and recent advances in coronavirus discovery. Pediatr Infect Dis J. https://doi.org/10.1097/01.inf.0000188166.17324.60

  • Khan S, Siddique R, Shereen MA, Ali A, Liu J, Bai Q, Bashir N, Xue M (2020) The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options. J Clin Microbiol. https://doi.org/10.1128/jcm.00187-20

  • Kuchler H, Mancini DP (2020) WHO and Roche Launch trials of potential coronavirus treatments. Swissinfo.Ch

    Google Scholar 

  • Kupferschmidt K (2020) Trials of drugs to prevent coronavirus infection begin in health care workers. Science

    Google Scholar 

  • Laires MJ, Monteiro C (2008) Exercise, magnesium and immune function. Magnes Res. https://doi.org/10.1684/mrh.2008.0136

  • Langlois PL, D’Aragon F, Hardy G, Manzanares W (2019) Omega-3 polyunsaturated fatty acids in critically ill patients with acute respiratory distress syndrome: a systematic review and meta-analysis. Nutrition. https://doi.org/10.1016/j.nut.2018.10.026

  • Laviano A, Koverech A, Zanetti M (2020) Nutrition support in the time of COVID-19. Nutrition. https://doi.org/10.1016/j.nut.2020.110834

  • Leneva IA, Russell RJ, Boriskin YS, Hay AJ (2009) Characteristics of Arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of Arbidol. Antivir Res. https://doi.org/10.1016/j.antiviral.2008.10.009

  • Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G et al (2020) Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. https://doi.org/10.14336/ad.2020.0228

  • Leung NHL, Chu DKW, Shiu EYC, Chan K-H, McDevitt JJ, Hau BJP, Yen H-L et al (2020) Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. https://doi.org/10.1038/s41591-020-0843-2

  • Li X, Geng M, Peng Y, Meng L, Shemin L (2020) Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. https://doi.org/10.1016/j.jpha.2020.03.001

  • Liang H, Acharya G (2020) Novel Corona virus disease (COVID-19) in pregnancy: what clinical recommendations to follow? Acta Obstet Gynecol Scand. https://doi.org/10.1111/aogs.13836

  • Lin MH, Moses DC, Hsieh CH, Cheng SC, Chen YH, Sun CY, Chou CY (2018a) Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes. Antivir Res. https://doi.org/10.1016/j.antiviral.2017.12.015

  • Lin PH, Sermersheim M, Li H, Lee PHU, Steinberg SM, Ma J (2018b) Zinc in wound healing modulation. Nutrients. https://doi.org/10.3390/nu10010016

  • Lin J, Zhang Y, Zhu X, Wang D, Dai J (2020) Effects of supplementation with Omega-3 fatty acids during pregnancy on asthma or wheeze of children: A systematic review and Meta-analysis. J Matern Fetal Neonatal Med. https://doi.org/10.1080/14767058.2018.1529161

  • Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, Li Y, Hu Z, Wu Z, Wang M (2020a) Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. https://doi.org/10.1038/s41421-020-0156-0

  • Liu Q, Wang R, Guoqiang Q, Wang Y, Pan L, Zhu Y, Fei G, Ren L, Zhou Y, Liang (2020b) Anatomy of a new coronavirus pneumonia death corpse system (Chinese). J Forensic Med China 36(1):21–23. https://doi.org/10.12116/j.issn.1004-5619.2020.01.005

    Article  CAS  Google Scholar 

  • Lokugamage KG, Hage A, Schindewolf C, Rajsbaum R, Menachery VD (2020) SARS-CoV-2 is sensitive to type I interferon pretreatment. BioRxiv

    Google Scholar 

  • Lu H (2020) Drug treatment options for the 2019-new coronavirus (2019-NCoV). Biosci Trends. https://doi.org/10.5582/bst.2020.01020

  • Lu X, Zhang L, Hui D, Zhang J, Li YY, Jingyu Q, Zhang W et al (2020) SARS-CoV-2 infection in children. N Engl J Med. https://doi.org/10.1056/nejmc2005073

  • Maggini S, Beveridge S, Sorbara PJP, Senatore G (2008) Feeding the immune system: the role of micronutrients in restoring resistance to infections. CAB Rev Perspect Agric Vet Sci Nutr Nat Resour. https://doi.org/10.1079/PAVSNNR20083098

  • Maggini S, Pierre A, Calder PC (2018) Immune function and micronutrient requirements change over the life course. Nutrients. https://doi.org/10.3390/nu10101531

  • Mallick R, Basak S, Duttaroy AK (2019) Docosahexaenoic Acid,22:6n-3: its roles in the structure and function of the brain. Int J Dev Neurosci 79(December):21–31. https://doi.org/10.1016/j.ijdevneu.2019.10.004

    Article  CAS  PubMed  Google Scholar 

  • MannKind (2020) MannKind refocuses pipeline resources in response to COVID-19 pandemic. MannKind

    Google Scholar 

  • Martinez MA (2020) Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob Agents Chemother. https://doi.org/10.1128/aac.00399-20

  • Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, Shimojima M, Fukushi S (2020) The inhaled corticosteroid Ciclesonide blocks coronavirus RNA replication by targeting viral NSP15. BioRxiv. https://doi.org/10.1101/2020.03.11.987016

  • Mesoblast (2020) Mesoblast to evaluate anti-inflammatory cell therapy Remestemcel-L for treatment of COVID-19 lung disease

    Google Scholar 

  • Metcalfe SM (2020) Mesenchymal stem cells and management of COVID-19 pneumonia. Med Drug Discov. https://doi.org/10.1016/j.medidd.2020.100019

  • Miyata J, Arita M (2015) Role of Omega-3 fatty acids and their metabolites in asthma and allergic diseases. Allergol Int. https://doi.org/10.1016/j.alit.2014.08.003

  • multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia (2020) Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi/Zhonghua Jiehe He Huxi Zazhi/Chin J Tuberculosis Respiratory Dis. https://doi.org/10.3760/cma.j.issn.1001-0939.2020.03.009

  • National Health Commission & State Administration of Traditional Chinese Medicine (2020) Diagnosis and treatment protocol for novel coronavirus pneumonia

    Google Scholar 

  • National Health Commission of the People’s Republic of China (2020) For different groups of people: how to choose masks. National Health Commission of the People’s Republic of China

    Google Scholar 

  • Omer SB, Malani P, Del Rio C (2020) The COVID-19 pandemic in the US: a clinical update. JAMA. https://doi.org/10.1001/jama.2020.5788

  • Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B (2020) COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. https://doi.org/10.1148/radiol.2020201187

  • PRNewswire (2020) Celularity announces FDA clearance of IND application for CYNK-001 in coronavirus, first in cellular therapy. PRNewswire

    Google Scholar 

  • QBioMed (2020) Q BioMed partner Mannin research developing potential treatment for patients infected with coronavirus and other infectious diseases. Q BioMed

    Google Scholar 

  • Raha S, Mallick R, Basak S, Duttaroy AK (2020) Is copper beneficial for COVID-19 patients? Med Hypotheses. https://doi.org/10.1016/j.mehy.2020.109814

  • Regeneron (2020) Regeneron announces important advances in novel COVID-19 antibody program

    Google Scholar 

  • RoivantSciences (2020) Roivant announces development of Anti-GM-CSF monoclonal antibody to prevent and treat acute respiratory distress syndrome (ARDS) in patients with COVID-19

    Google Scholar 

  • Ross AC (2012) Vitamin A and retinoic acid in T cell-related immunity. Am J Clin Nutr. https://doi.org/10.3945/ajcn.112.034637

  • Rothan HA, Stone S, Natekar J, Kumari P, Arora K, Kumar M (2020) The FDA-approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells. BioRxiv. (Preprint)

    Google Scholar 

  • Royal College of Physicians (2017) National Early Warning Score (NEWS) 2 | RCP London. NEWS 2

    Google Scholar 

  • Saeed F, Nadeem M, Ahmed RS, Nadeem MT, Arshad MS, Ullah A (2016) Studying the impact of nutritional immunology underlying the modulation of immune responses by nutritional compounds – a review. Food Agric Immunol. https://doi.org/10.1080/09540105.2015.1079600

  • Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A (2020) Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients. Panminerva Med. https://doi.org/10.23736/S0031-0808.20.03897-5

  • Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R (2003) Effects of chloroquine on viral infections: an old drug against Today’s diseases? Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(03)00806-5

  • Sheahan TP, Sims AC, Zhou S, Graham RL, Pruijssers AJ, Agostini ML, Leist SR et al (2020) An orally bioavailable broad-Spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med 5883:1–21. https://doi.org/10.1126/scitranslmed.abb5883

    Article  CAS  Google Scholar 

  • Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F et al (2020) Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. J Am Med Assoc. https://doi.org/10.1001/jama.2020.4783

  • Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W et al (2020) Association of Cardiac Injury With Mortality In hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.0950

  • Simpson TF, Kovacs RJ, Stecker EC (2020) Ventricular arrhythmia risk due to hydroxychloroquine-azithromycin treatment for COVID-19. American College of Cardiology; Cardiology Magazine

    Google Scholar 

  • Singh R, Adhikari R (2020) Age-structured impact of social distancing on the COVID-19 epidemic in India. ArXiv Popul Evol

    Google Scholar 

  • Sisk JM, Frieman MB, Machamer CE (2018) Coronavirus S protein-induced fusion is blocked prior to Hemifusion by Abl kinase inhibitors. J Gen Virol. https://doi.org/10.1099/jgv.0.001047

  • Smith JD, MacDougall CC, Johnstone J, Copes RA, Schwartz B, Garber GE (2016) Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: A systematic review and Meta-analysis. CMAJ. https://doi.org/10.1503/cmaj.150835

  • Smith T, Prosser T, Clinical Drug Information, and Clinical Solutions (2020) COVID-19 drug therapy – potential options.” Elsevier’s Novel Coronavirus Information Center, no. March: 19–22

    Google Scholar 

  • Sodhi M, Etminan M (2020) Therapeutic potential for Tetracyclines in the treatment of COVID-19. Pharmacotherapy:0–3. https://doi.org/10.1002/phar.2395

  • Solnik C (2020) Northwell health initiates clinical trials of 2 COVID-19 drugs. Long Island Press

    Google Scholar 

  • Spapen HD, Jacobs R, Honoré PM (2017) Sepsis-induced multi-organ dysfunction syndrome—a mechanistic approach. J Emerg Crit Care Med. https://doi.org/10.21037/jeccm.2017.09.04

  • Stobbe M(2020) Wuhan coronavirus? 2019 NCoV? naming a new disease. Fortune

    Google Scholar 

  • Takeda (2020a) Rajeev Venkayya, President, Global Vaccine Business Unit on the Latest on the Coronavirus and Takeda. Takeda

    Google Scholar 

  • Takeda (2020b)Takeda initiates development of a plasma-derived therapy for COVID-19

    Google Scholar 

  • TASS (2020) China publishes coronavirus patients autopsy results, says infection sources determined. TASS-Russian News Agency

    Google Scholar 

  • Tönnesmann E, Kandolf R, Lewalter T (2013) Chloroquine cardiomyopathy-a review of the literature. Immunopharmacol Immunotoxicol. https://doi.org/10.3109/08923973.2013.780078

  • US Food and Drug Administration (2020a) FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19

    Google Scholar 

  • US Food and Drug Administration (2020b) QSARS-CoV-2 IgG/IgM rapid test

    Google Scholar 

  • Velthuis AJW t, van den Worml SHE, Sims AC, Baric RS, Snijder EJ, van Hemert MJ (2010) Zn2+ inhibits coronavirus and Arterivirus RNA polymerase activity in vitro and zinc Ionophores block the replication of these viruses in cell culture. PLoS Pathog. https://doi.org/10.1371/journal.ppat.1001176

  • Vetter P, Eckerle I, Kaiser L (2020) COVID-19: A puzzle with many missing pieces. BMJ. https://doi.org/10.1136/bmj.m627

  • Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG, Nichol ST (2005) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. https://doi.org/10.1186/1743-422X-2-69

  • VirBiotechnology (2020a) Generation bio and Vir biotechnology to collaborate on research to leverage scalable non-viral Gene therapy platform for durable production of monoclonal antibodies against coronavirus that causes COVID-19

    Google Scholar 

  • VirBiotechnology (2020b) Vir biotechnology announces intent to collaborate with biogen on manufacturing of antibodies to potentially treat COVID-19

    Google Scholar 

  • VirBiotechnology (2020c) Vir biotechnology announces research collaboration with the national institutes of health vaccine research center on antibodies against coronaviruses

    Google Scholar 

  • Walczyszyn M, Thirumala R, DiFabrizio L (2012) Antiphosphospholipid syndrome with multi-system organ failure. J Gen Intern Med

    Google Scholar 

  • Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B et al (2020a) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. https://doi.org/10.1001/jama.2020.1585

  • Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, Yaffe MB, Moore HB, Barrett CD (2020b) Tissue plasminogen activator (TPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series. J Thromb Haemost. https://doi.org/10.1111/jth.14828

  • Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Wu Z, Xiao G (2020c) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-NCoV) in vitro. Cell Res. https://doi.org/10.1038/s41422-020-0282-0

  • Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W (2020d) Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. https://doi.org/10.1001/jama.2020.3786

  • WHO (2020a) Clinical management of when novel coronavirus is suspected: severe acute respiratory infections what to do and what not to do. WHO-Interim Guidance

    Google Scholar 

  • WHO (2020b) Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. WHO – Interim Guidance

    Google Scholar 

  • WHO (2020c) Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization

    Google Scholar 

  • WHO (2020d) WHO clinical management of Severe Acute Respiratory Infection (SARI) when COVID-19 disease is suspected. WHO - Interim Guidance

    Google Scholar 

  • WHO Interm Guidance (2020) Infection prevention and control for the safe management of a dead body in the context of COVID-19. J Hosp Infect 104(3):246–251. https://doi.org/10.1016/j.jhin.2020.01.022

    Article  Google Scholar 

  • Wiles S (2020a) After ‘Flatten the curve’, we must now ‘Stop the spread’. Here’s what that means. The Spinoff

    Google Scholar 

  • Wiles S (2020b) The three phases of COVID-19 – and how we can make it manageable. The Spinoff

    Google Scholar 

  • Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. https://doi.org/10.1001/jama.2020.2648

  • Wu C, Chen X, Cai Y, Xia J’a, Zhou X, Xu S, Huang H et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.0994

  • Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F et al (2020) Inhibition of SARS-CoV-2 infection (previously 2019-NCoV) by a highly potent Pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. https://doi.org/10.1101/2020.03.09.983247

  • Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S et al (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30076-X

  • Yamaya M, Nishimura H, Xue D, Sugawara M, Watanabe O, Nomura K, Shimotai Y, Momma H, Ichinose M, Kawase T (2020) Inhibitory effects of Glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig. https://doi.org/10.1016/j.resinv.2019.12.005

  • Yang Y, Zhang K, Wang Y, Li M, Sun X, Liang Z, Wang L, Chen L, Yang H, Zhu L (2016) Disulfiram chelated with copper promotes apoptosis in human breast cancer cells by impairing the mitochondria functions. Scanning. https://doi.org/10.1002/sca.21332

  • Yao X, Ye F, Zhang M, Cheng C, Huang B, Niu P, Xu L et al (2020) In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. https://doi.org/10.1093/cid/ciaa237

  • Yoshii K, Hosomi K, Sawane K, Kunisawa J (2019) Metabolism of dietary and microbial vitamin b family in the regulation of host immunity. Front Nutr. https://doi.org/10.3389/fnut.2019.00048

  • Zhang C, Zhang Y, Qin Y, Zhang Q, Liu Q, Shang D, Lu H et al (2019) Ifenprodil and Flavopiridol identified by Genomewide RNA interference screening as effective drugs to ameliorate murine acute lung injury after influenza A H5N1 virus infection. MSystems. https://doi.org/10.1128/msystems.00431-19

  • Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q (2020a) The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2020.105954

  • Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, Chen H et al (2020b) Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. https://doi.org/10.1056/NEJMc2007575

  • Zheng YY, Ma YT, Zhang JY, Xie X (2020) COVID-19 and the cardiovascular system. Nat Rev Cardiol. https://doi.org/10.1038/s41569-020-0360-5

  • Zhou F, Yu T, Ronghui D, Fan G, Liu Y, Liu Z, Xiang J et al (2020a) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. https://doi.org/10.1016/S0140-6736(20)30566-3

  • Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R et al (2020b) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. https://doi.org/10.1038/s41586-020-2012-7

Download references

Acknowledgments

This study was supported in part by the Faculty of Medicine, University of Oslo.

Conflict of Interest

The authors report no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland

    Rahul Mallick

  2. Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway

    Asim K. Duttaroy

Authors
  1. Rahul Mallick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asim K. Duttaroy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Asim K. Duttaroy .

Editor information

Editors and Affiliations

  1. President & CEO, NampEVA BioTherapeutics LLC, Dover, DE, USA

    Alexzander A. A. Asea

  2. Department of Medicine and Precision Therapeutics Proteogenomics Diagnostic Center Eleanor N. Dana Cancer Center, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

    Punit Kaur

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mallick, R., Duttaroy, A.K. (2021). Clinical Features, Diagnostic Evaluation, and Management of COVID-19 Patients. In: Asea, A.A.A., Kaur, P. (eds) Coronavirus Therapeutics – Volume II. Advances in Experimental Medicine and Biology, vol 1353. Springer, Cham. https://doi.org/10.1007/978-3-030-85113-2_1

Download citation

Publish with us

Policies and ethics

Search

Navigation